Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.30
PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United States. The company is headquartered in Laguna Hills, California.
See the full interactive analysis & chart →Informational only — not investment advice.